| Dr Brooke Nielsen Tabone, PHARMD | |
|
317 E 100 N Ste 4, Price, UT 84501-2504 | |
| (435) 637-6337 | |
| Not Available |
| Full Name | Dr Brooke Nielsen Tabone |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 317 E 100 N Ste 4, Price, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356851448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 333267-1701 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brooke Nielsen Tabone, PHARMD 450 Woodhill Dr, Price, UT 84501-2436 Ph: (435) 650-3848 | Dr Brooke Nielsen Tabone, PHARMD 317 E 100 N Ste 4, Price, UT 84501-2504 Ph: (435) 637-6337 |
News Archive
A recent Mayo Clinic study found that people with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI) - and chances are that it will include memory loss. The study was recently published in Mayo Clinic Proceedings.
When Sen. Elizabeth Steiner Hayward walked into a committee meeting, she didn't plan to reveal to the world that she has suffered from major depression for 15 years. "If I go two days without taking my medication, I can't walk in the door of this building," Steiner Hayward, D-Beaverton, told colleagues. "I can't get up in the morning. I can't take a shower. I can't function as a normal human being." Steiner Hayward is coming forward as a public voice for mental health at a time when Oregon lawmakers are considering Senate Bill 823, which would significantly expand mental health care in Oregon (Zheng, 6/3).
Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American Association for Cancer Research in Washington, DC (Abstracts 3698 and 5534).
Myc cancer gene empowers tumor cells to relentlessly divide but simultaneously, provokes a cell suicide process called apoptosis. Myc controls cells by commanding the expression of every tenth of the genes in the nucleus of a tumor cell. However, in spite of more than two decades of intense research, no Myc motivated killer genes have been found.
› Verified 2 days ago
Kelli Fowles, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Smith's Food & Drug, 1075 E Main St, Price, UT 84501 Phone: 435-637-0804 Fax: 435-637-4628 | |
Steven Scow, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1075 E Main St, Price, UT 84501 Phone: 435-637-0840 | |
Mr. Kenneth Paul Topolovec, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Price River Dr, Price, UT 84501 Phone: 435-637-0806 Fax: 435-637-6153 | |
Mr. Mikel Chad Cowdell, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 N Hospital Dr, Price, UT 84501 Phone: 435-636-4800 | |
Rhonda Raye Ohlin, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Price River Dr, Price, UT 84501 Phone: 435-637-0806 Fax: 435-637-6153 | |
Pamela Burt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 S Highway 55, Price, UT 84501 Phone: 435-637-6974 Fax: 435-637-8557 |